Biotech

All Articles

Roivant reveals new 'vant' to advance Bayer hypertension med

.Matt Gline is actually back along with a brand-new 'vant' firm, after the Roivant Sciences CEO paid...

Viridian eye illness stage 3 hits, accelerating press to rival Amgen

.Viridian Therapies' phase 3 thyroid eye illness (TED) scientific trial has actually hit its major a...

Bain reveals $3B fund for life science business

.Along with a sturdy record for determining diamonds in the rough, Bain Financing Life Sciences (BCL...

Genentech's cancer restructure brought in 'for clinical reasons'

.The recent choice to combine Genentech's 2 cancer cells divisions was actually created "scientific ...

Tern dental GLP-1 reveals 5% weight reduction at 1 month at best dose

.Terns Pharmaceuticals' decision to lose its liver disease ambitions may however settle, after the b...

Merck, Daiichi regular early results in little cell lung cancer with upgraded ADC data

.Merck &amp Co.'s long-running effort to land a hit on tiny tissue lung cancer cells (SCLC) has actu...

Boehringer, Bayer breakthrough bronchi cancer medications toward Astra struggle

.Some individuals with non-small tissue lung cancer (NSCLC) have anomalies in a gene called individu...

MBX aims for $136M IPO to take rival to Ascendis into phase 3

.MBX has actually expanded programs to consume over $136 million coming from its own IPO as the biot...

Relay bosom cancer cells data tee up clash with AstraZeneca's Truqap

.Relay Therapies has actually hammered its survival objective in a first-in-human breast cancer rese...

AZ outlines AI-enabled TROP2 biomarker technique for Daiichi ADC

.AstraZeneca has used expert system to develop a special biomarker for its Daiichi Sankyo-partnered ...